Wall Street secured gains again by late afternoon Wednesday in unpredictable trading following President-elect Donald Trump's first press conference since July. The Volatility Index, otherwise known as the fear index, spiked earlier in the session. Biotech companies and drugmakers were broadly lower after Trump suggested he would aggressively negotiate the price the U.S. pays for drugs. Stocks including Allergan (AGN) , Mylan (MYL) , Perrigo (PRGO) , Valeant (VRX) and Bristol-Myers Squibb (BMY) slumped after Trump's late-morning presser. Workday (WDAY) climbed after Walmart (WMT) signed up for a subscription, a deal that will likely cover the highest number of workers in the company's history. The world's largest retailer has more than two million employees worldwide. Volkswagen (VLKAY) rose after securing a plea deal with U.S. regulators worth $4.3 billion. The case covered the automaker's highly-publicized emissions-rigging scandal.
More from Video
Despite the president's promise of no stimulus until after Nov. 3, there are no signs yet that this is the sort of correlated selling that leads to a deep correction.
Salesforce, Amgen and Honeywell will give a lift to the DJIA going forward.
CAG has hung onto the bulk of its recent gains, and could rise to the $50 area, according to the charts and indicators.
Breaking down an approach to the long side of this biotech stock.